pronetalol
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Beta-2 adrenergic receptorANTAGONIST
ADRB2 antagonist
Non-selective beta blocker clinical candidate. It was never used clinically.
- Beta-1 adrenergic receptorANTAGONIST
ADRB1 antagonist
Non-selective beta blocker clinical candidate. It was never used clinically.
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)NCC(O)c1ccc2ccccc2c1- Mol. weight
- 229.32 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL16476 ↗
- ChEMBLCHEMBL1201533 ↗
- ChEMBLCHEMBL1201532 ↗
Also known as
- 2-naphthalenemethanol, alpha-(((1-methylethyl)amino)methyl)-
- ay-6204 hcl
- ay-6204 hcl
- dl-pronethalol
- gnf-pf-2670
- gnf-pf-2670
- ici-38174 [as hydrochloride]
- ici-38174 [as hydrochloride]
- naphthylisoproterenol
- naphthylisoproterenol
- nethalide
- nethalide
- nethalide
- pronetalol
- pronetalol
- pronetalol
- pronetalol
- pronetalol
- pronetalol
- pronetalol
- pronetalol
- pronethalol
- pronethalol
- pronethalol
- pronethalol
- (+/-)-pronethalol
- pronethalol hcl
- pronethalol hydrochloride